| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |